strabag se-br (STR:Vienna)

Executive Profile*

Background*

Dr. Peter H. Krammer, M.D. serves as Scientific Advisor of Apogenix GmbH. Dr. Krammer serves as coordinator of the research program Tumor Immunology at German Cancer Research Center (DKFZ) and Head of the Division of Immunogenetics. Prof. Krammer has been a Member of Management Board at Strabag SE since October 1, 2009. Dr. Krammer served as Deputy Member of the Management Board of STRABAG SE since January 1, 2010. His professional experience has included positions at ... Por Technobau AG, Swietelsky Bau GesmbH and STRABAG AG, Austria. In 2005, he joined the management board of STRABAG AG in charge of building construction and civil engi neering in Eastern Europe and of environmental technology for the entire STRABAG. He serves as a Member of Supervisory Board at Ed. Züblin AG. He serves as Member of the Advisory Board of Apogenix GmbH. He served as its Member of the Supervisory Board at Apogenix GmbH. He is one of the world's most renowned apoptosis researchers and has been awarded numerous prestigious awards and honours, such as the Robert Koch Prize, the Avery-Landsteiner Prize, the Ernst Jung Prize and the Order of Merit of the Federal Republic of Germany. He studied civil engineering at the Technical University in Vienna, completed his studies in 1995 with a doctorate degree in engineering sciences.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
STR:AV	€16.38 EUR	+0.08

COMPETITOR COMPENSATION